BrightSpring (BTSG) officer gets equity grants, sells shares

Rhea-AI Filing Summary

BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of equity grants, option activity, and share sales. On March 4, 2026, he exercised 220,000 stock options at $6.37 per share and sold 220,000 common shares at $41.15 per share in a registered public offering.

On March 4–5, 2026, he was awarded several blocks of stock options and restricted stock units (RSUs), including 458,008 options, 955,823 options, and 186,845 RSUs. Some options are fully vested, while others and the RSUs vest in twelve equal quarterly installments starting April 25, 2026. After these transactions, he directly owned about 1,023,880 common shares, plus additional option and share interests held indirectly through family trusts, for which he disclaims beneficial ownership beyond his economic interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROUSSEAU JON B

(Last) (First) (Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE KY 40222

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		M		220,000	A	$6.37	1,243,880	D
Common Stock	03/04/2026		S(1)		220,000	D	$41.15(1)	1,023,880	D
Common Stock	03/05/2026		A(2)		186,845	A	$0	1,210,725	D
Common Stock								369,763	I	By Rousseau Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$6.37	03/04/2026		A		955,823		(4)	10/16/2029	Common Stock	955,823	$0	1,516,064	D
Stock Options (Right to Buy)	$6.37	03/04/2026		M			220,000	(5)	10/16/2029	Common Stock	220,000	$0	1,296,064	D
Stock Options (Right to Buy)	$41.77	03/05/2026		A		458,008		(6)	03/05/2036	Common Stock	458,008	$0	458,008	D
Stock Options (Right to Buy)	$6.37							(5)	10/16/2029	Common Stock	534,676		534,676	I	By The Margaret Rousseau Children Trust(3)
Stock Options (Right to Buy)	$6.37							(5)	10/16/2029	Common Stock	377,602		377,602	I	By Rousseau Family Trust(3)

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.

2. On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in twelve equal quarterly installments commencing on April 25, 2026. Each RSU represents a contingent right to receive one share of common stock upon settlement.

3. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.

4. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on October 16, 2019, vesting subject to performance conditions that were subsequently satisfied on March 3, 2026. The Performance Options are fully vested.

5. These options are fully vested.

6. Options vest in twelve equal quarterly installments commencing on April 25, 2026.

Remarks:

Title: Chairman, President and Chief Executive Officer

	/s/ Jennifer Phipps, as Attorney-in-Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Jon B. Rousseau report at BrightSpring (BTSG)?

Jon B. Rousseau reported exercising 220,000 stock options at $6.37 and selling 220,000 BrightSpring common shares at $41.15 in a registered public offering, alongside multiple new option and restricted stock unit awards granted on March 4–5, 2026.

How many BrightSpring (BTSG) shares did Jon B. Rousseau sell and at what price?

He sold 220,000 shares of BrightSpring common stock at $41.15 per share. According to the disclosure, this sale occurred on March 4, 2026, as part of a registered public offering, before underwriting discounts and commissions were deducted from the transaction.

What new equity awards did Jon B. Rousseau receive from BrightSpring (BTSG)?

He received grants of 458,008 stock options, 955,823 stock options, and 186,845 restricted stock units. The filing notes that some options are fully vested, while others and the RSUs will vest over twelve equal quarterly installments beginning April 25, 2026.

How do Jon B. Rousseau’s new RSUs at BrightSpring (BTSG) vest?

The restricted stock units granted on March 5, 2026 vest in twelve equal quarterly installments starting April 25, 2026. Each RSU represents a contingent right to receive one BrightSpring common share when the units are settled after vesting requirements are satisfied.

What is Jon B. Rousseau’s BrightSpring (BTSG) share ownership after these transactions?

Following the reported transactions, he directly held 1,023,880 shares of BrightSpring common stock. He also has additional indirect interests in stock and options through family trusts, while formally disclaiming beneficial ownership beyond his pecuniary interest in those securities.

Were Jon B. Rousseau’s BrightSpring (BTSG) stock options newly granted or vesting awards?

Some options reflect performance-based awards originally granted in 2019 that fully vested after conditions were met on March 3, 2026. Another option grant will vest in twelve equal quarterly installments beginning April 25, 2026, according to the detailed transaction footnotes.